Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2010

01-07-2010 | Case Report

Multiple sclerosis attacks triggered by hyperprolactinemia

Authors: V. Nociti, G. Frisullo, T. Tartaglione, A. K. Patanella, R. Iorio, P. A. Tonali, A. P. Batocchi

Published in: Journal of Neuro-Oncology | Issue 3/2010

Login to get access

Abstract

Multiple sclerosis (MS) is a T-cell autoimmune disease of the central nervous system (CNS). Predominance of women in autoimmune diseases suggests that sex hormones may play a role in disease susceptibility. A possible role for prolactin, a neuroendocrine peptide with powerful immunomodulatory properties, is suggested in MS. We describe the case of a 32-year-old man affected by relapsing-remitting MS who experienced the first MS clinical event during the development of a prolactin-secreting adenoma and the only two MS relapses during adenoma recurrence. Prolactin may have facilitated the inflammatory process and triggered MS clinical attacks, suggesting a role of prolactin in immunomodulation and therefore in autoimmune disease course.
Literature
1.
go back to reference Weiner HL (2004) Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol 61:1613–1615CrossRefPubMed Weiner HL (2004) Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol 61:1613–1615CrossRefPubMed
2.
go back to reference Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65:239–248CrossRefPubMed Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65:239–248CrossRefPubMed
3.
go back to reference Tomio A, Schust DJ, Kawana K, Yasugi T, Kawana Y, Mahalingaiah S et al (2008) Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet. Immunol Cell Biol 86:616–621CrossRefPubMed Tomio A, Schust DJ, Kawana K, Yasugi T, Kawana Y, Mahalingaiah S et al (2008) Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet. Immunol Cell Biol 86:616–621CrossRefPubMed
4.
go back to reference Riskind PN, Massacesi L, Doolittle TH, Hauser SL (1991) The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 29(5):542–547CrossRefPubMed Riskind PN, Massacesi L, Doolittle TH, Hauser SL (1991) The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol 29(5):542–547CrossRefPubMed
5.
go back to reference Kira J, Harada M, Yamaguchi Y, Shida N, Goto I (1991) Hyperprolactinemia in multiple sclerosis. J Neurol Sci 102:61–66CrossRefPubMed Kira J, Harada M, Yamaguchi Y, Shida N, Goto I (1991) Hyperprolactinemia in multiple sclerosis. J Neurol Sci 102:61–66CrossRefPubMed
6.
go back to reference Bissay V, De Klippel N, Herroelen L, Schmedding E, Buisseret T, Ebinger G et al (1994) Bromocriptine therapy in multiple sclerosis: an open label pilot study. Clin Neuropharmacol 17:473–476CrossRefPubMed Bissay V, De Klippel N, Herroelen L, Schmedding E, Buisseret T, Ebinger G et al (1994) Bromocriptine therapy in multiple sclerosis: an open label pilot study. Clin Neuropharmacol 17:473–476CrossRefPubMed
7.
go back to reference Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M et al (2006) Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis—reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol 6:19CrossRefPubMed Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M et al (2006) Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis—reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol 6:19CrossRefPubMed
8.
go back to reference Yang L, Hu Y, Li X, Zhao J, Hou Y (2006) Prolactin modulates the functions of murine spleen CD11c-positive dendritic cells. Int Immunopharmacol 6:1478–1486CrossRefPubMed Yang L, Hu Y, Li X, Zhao J, Hou Y (2006) Prolactin modulates the functions of murine spleen CD11c-positive dendritic cells. Int Immunopharmacol 6:1478–1486CrossRefPubMed
9.
go back to reference Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW et al (2007) White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27:1812–1823CrossRefPubMed Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW et al (2007) White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27:1812–1823CrossRefPubMed
10.
go back to reference Langer-Gould A, Huang SM, Gupta R, Leimpeter AD, Greenwood E, Albers KB et al (2009) Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 66:958–963CrossRefPubMed Langer-Gould A, Huang SM, Gupta R, Leimpeter AD, Greenwood E, Albers KB et al (2009) Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol 66:958–963CrossRefPubMed
11.
go back to reference Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P et al (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127:1353–1360CrossRefPubMed Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P et al (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127:1353–1360CrossRefPubMed
12.
go back to reference Sodhi A, Tripathi A (2008) Prolactin induced production of cytokines in macrophages involves Ca++ and p42/44 MAP kinase signaling pathway. Growth Factors 26:212–219CrossRefPubMed Sodhi A, Tripathi A (2008) Prolactin induced production of cytokines in macrophages involves Ca++ and p42/44 MAP kinase signaling pathway. Growth Factors 26:212–219CrossRefPubMed
Metadata
Title
Multiple sclerosis attacks triggered by hyperprolactinemia
Authors
V. Nociti
G. Frisullo
T. Tartaglione
A. K. Patanella
R. Iorio
P. A. Tonali
A. P. Batocchi
Publication date
01-07-2010
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2010
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-009-0076-1

Other articles of this Issue 3/2010

Journal of Neuro-Oncology 3/2010 Go to the issue

Laboratory Investigation - Human/Animal Tissue

Overexpression of septin 7 suppresses glioma cell growth